These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35006112)

  • 1. Incidental Uptake of 18F-Fluciclovine by Type AB Thymoma.
    Somnay V; Dalal I
    Clin Nucl Med; 2022 Feb; 47(2):e116-e117. PubMed ID: 35006112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18F-Fluciclovine Uptake in Thymoma Demonstrated on PET/MRI.
    Tsikitas L; Karls S; Kranz AO; Friedman KP; Mahajan S
    Clin Nucl Med; 2021 Mar; 46(3):e168-e170. PubMed ID: 32956127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extraprostatic Uptake of
    Robertson MS; Sakellis CG; Hyun H; Jacene HA
    AJR Am J Roentgenol; 2020 Mar; 214(3):641-648. PubMed ID: 31939697
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostate cancer recurrence in patients with negative or equivocal conventional imaging: A role for
    Kim EH; Siegel BA; Teoh EJ; Andriole GL;
    Urol Oncol; 2021 Jun; 39(6):365.e9-365.e16. PubMed ID: 33160848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidental Detection of Urothelial Carcinoma on 18F-Fluciclovine PET/CT.
    Surasi DSS; Lu Y; Corn P; Pettaway C; Bathala T
    Clin Nucl Med; 2021 Feb; 46(2):e114-e115. PubMed ID: 33156041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidental 18F-Fluciclovine Uptake in a Desmoid Tumor Detected in a Patient Undergoing PET/CT Imaging for Prostate Cancer.
    Baiomy A; Jensen CT; Ward JF; Chasen BA; Ravizzini GC
    Clin Nucl Med; 2021 Apr; 46(4):355-357. PubMed ID: 33323736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial Institutional Experience with 18F-Fluciclovine PET-CT in Biochemical Recurrence of Prostate Cancer.
    Farkas AB; Green ED; Thaggard AL; Vijayakumar V; Henegan JC; Lirette ST; Nittala MR; Vijayakumar S
    South Med J; 2021 Nov; 114(11):703-707. PubMed ID: 34729614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-Fluciclovine-Avid Pulmonary Hamartoma.
    Baldeosingh SC; Rowe SP; Greco SC; Paller CJ; Goel R
    Clin Nucl Med; 2021 Nov; 46(11):919-921. PubMed ID: 34582137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic Male Breast Cancer With Increased Uptake on 18F-Fluciclovine PET/CT Scan.
    Gill HS; Tade F; Greenwald DT; Yonover PM; Savir-Baruch B
    Clin Nucl Med; 2018 Jan; 43(1):23-24. PubMed ID: 29189374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorine-18-Labeled Fluciclovine PET/CT in Clinical Practice: Factors Affecting the Rate of Detection of Recurrent Prostate Cancer.
    Savir-Baruch B; Lovrec P; Solanki AA; Adams WH; Yonover PM; Gupta G; Schuster DM
    AJR Am J Roentgenol; 2019 Oct; 213(4):851-858. PubMed ID: 31216198
    [No Abstract]   [Full Text] [Related]  

  • 11. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent prostate cancer detection with anti-3-[(18)F]FACBC PET/CT: comparison with CT.
    Odewole OA; Tade FI; Nieh PT; Savir-Baruch B; Jani AB; Master VA; Rossi PJ; Halkar RK; Osunkoya AO; Akin-Akintayo O; Zhang C; Chen Z; Goodman MM; Schuster DM
    Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1773-83. PubMed ID: 27091135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papillary Urothelial Carcinoma of Urinary Bladder Identified on 18F-Fluciclovine PET/CT.
    Meka VM; Wankhar B; Ojili V; Batchala PP
    Clin Nucl Med; 2021 Aug; 46(8):e438-e439. PubMed ID: 33782311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent Malignant Melanoma Detected on 18F-Fluciclovine PET/CT Imaging for Prostate Cancer.
    Teoh EJ; Tsakok MT; Bradley KM; Hyde K; Subesinghe M; Gleeson FV
    Clin Nucl Med; 2017 Oct; 42(10):803-804. PubMed ID: 28806256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Positron Emission Tomography with 18F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial.
    Andriole GL; Kostakoglu L; Chau A; Duan F; Mahmood U; Mankoff DA; Schuster DM; Siegel BA;
    J Urol; 2019 Feb; 201(2):322-331. PubMed ID: 30179618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-fluciclovine PET/CT detection of biochemical recurrent prostate cancer in patients with PSA levels <2.00 ng/mL.
    Garza D; Kandathil A; Xi Y; Subramaniam RM
    Nucl Med Commun; 2021 Aug; 42(8):907-913. PubMed ID: 33741863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidental Serous Cystadenoma Presenting as a Photopenic Pancreatic Defect on 18F-Fluciclovine PET/CT.
    Waltz J; Mercer MK; Dani G; Rieter WJ
    Clin Nucl Med; 2021 Dec; 46(12):e600-e602. PubMed ID: 34735415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidental Detection of Lung Adenocarcinoma Presenting as an Anterior Mediastinal Mass on 18F-Fluciclovine PET/CT in a Patient With Primary Prostate Cancer.
    Abiodun-Ojo OA; Akintayo AA; Sica GL; Alemozaffar M; Schuster DM
    Clin Nucl Med; 2020 Dec; 45(12):e525-e527. PubMed ID: 32701811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Additional Primary Neoplasms on
    Parihar AS; Schmidt LR; Dehdashti F; Wahl RL
    J Nucl Med; 2022 May; 63(5):713-719. PubMed ID: 34413144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective evaluation of fluciclovine (
    Akin-Akintayo O; Tade F; Mittal P; Moreno C; Nieh PT; Rossi P; Patil D; Halkar R; Fei B; Master V; Jani AB; Kitajima H; Osunkoya AO; Ormenisan-Gherasim C; Goodman MM; Schuster DM
    Eur J Radiol; 2018 May; 102():1-8. PubMed ID: 29685521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.